Future of risk based monitoring in clinical trials
Drug development is a complex and resource intensive endeavor. The average cost of developing a new drug, has been estimated to be $2 to $3 billion. However, the success rate of clinical trials is very low around and is estimated to be between 3-5%. The common reasons for failure of clinical trials...
Saved in:
Published in | International Journal of Clinical Trials Vol. 7; no. 3; p. 221 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
21.07.2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!